We have been working on an exciting new product - The Cancer Mutation Census (CMC). We are often asked which are the mutations that matter the most, the CMC will help to answer this question! The CMC allows for the prioritisation of somatic mutations that introduce biologically relevant changes to protein function, and participate in the development of cancer.
The CMC integrates all coding somatic mutations collected by COSMIC with biological and biochemical information from multiple sources, combining data obtained from manual curation and computational analyses.
It was a shame miss our usual face-to-face networking at the AACR, but at least we could share our latest developments on a poster.
27th May 2020
Following an outage 26th May 20, we can confirm our normal service has been resumed.
We have an exciting new product, The Cancer Mutation Census, as well as expertly curated genes and drug resistance data in our July release.
Our team have been working tirelessly to bring a huge amount of data to you in this release! Read about some of the content before heading over to the release notes.
In these trying times we are still producing the COSMIC v91 release for you! We're almost ready but in the meantime, we are sharing some more information about what you can expect to see.
The V91 release is coming soon. Find out about the newly curated genes, plus our other developments for the upcoming release .
Today is World Cancer Day and the 16th anniversary of the COSMIC database. Today we thought we would share our stories. Describe what the different members of the team do day to day and and the motivations behind our work.
There has been recent media coverage, including this Guardian article, about breast implant-associated cancer. The COSMIC Curation team have been hard at work looking into the various aspects of this disease and curating papers for the v91 release in March.